IL38357A - 2-phenyl-4-acylamido-imidazole derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

2-phenyl-4-acylamido-imidazole derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL38357A
IL38357A IL38357A IL3835771A IL38357A IL 38357 A IL38357 A IL 38357A IL 38357 A IL38357 A IL 38357A IL 3835771 A IL3835771 A IL 3835771A IL 38357 A IL38357 A IL 38357A
Authority
IL
Israel
Prior art keywords
compound
group
acetamido
imidazole
formula
Prior art date
Application number
IL38357A
Other versions
IL38357A0 (en
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of IL38357A0 publication Critical patent/IL38357A0/en
Publication of IL38357A publication Critical patent/IL38357A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1378381 Imidazoles BEECHAM GROUP Ltd 13 July 1972 [18 Aug 1971] 38716/71 Heading C2C The invention comprises novel compounds (I) wherein R and R 1 are each a hydrogen or halogen atom or a methoxycarbonyl, ethoxycarbonyl, carboxamido, nitro, trifluoromethyl, C 1-4 alkyl, hydroxyl, methoxyl, ethoxyl, benzyloxyl, acetoxyl, amino, methylamino, ethylamino, dimethylamino or acetamido group; R 2 is an amino or C 1-4 alkoxyl or benzyloxyl group; R 3 is a hydrogen atom or a C 1-7 hydrocarbon group; and R 4 is a hydrogen atom or a methyl group; or a tautomer, acid addition salt or hydrate thereof. They are made by standard methods. Pharmaceutical preparations showing antiinflammatory action contain (I) as active ingredient; administration may be orally, parenterally or by suppository. [GB1378381A]

Claims (9)

1. CLAIMS 1. A compound of the formula (II) wherein R and are each/hydrogen or halogen atom or a nitro, trifluoromethyl, c^-4 ^lkyl, hydroxy, methoxy, ethoxy, benzyl- oxy, acetoxy amino, methylamino, ethylamino, dimethylamino or acetamido group; 2 is an amino or C, . alkoxy or benzyloxy group A group; R^ is a alk JkY and is a hydrogen atom or a methyl group? or a tautomer, acid addition salt or hydrate thereof.
2. A compound as i Claim 1 wherein ^ is a hydrogen atom.
3. A compound as in Claim 2 wherein 2 is an amino, methoxy or ethoxy group.
4. A compound of the formula (III): amino group. 8. A compound of the formula (IV): 38357 ¾ wherein R^ is as defined in Claim 1. 9. A compound as in Claim 8 wherein R^ is a hydrogen or halogen atom or a methyl, methoxy, nitro or trifluoromethyl group. 10. & compound as in Claim 9 wherein R-Lis a hydrogen atom. 11. A compound of the formula (V): ne atom or a met y or tr uoromet y group. 12. A compound as in Claim 11 wherein ^ is a halogen atom. 13. A compound as in Claim .12 wherei R is a chlorine atom. 14. A compound as in Claim 12 wherein R^ is a fluorine atom. 1
5. 5--Acetamidb-4~carbainoyl~2~phenylimidazole. 1
6. 5-Acetamido-4-carbaiaoyl~2~ (p-fluorophenyl) imidazole. 1
7. 5-Propionamido-4-carbamoyl-2- (p-'fluorophenyl) imidazole. 1
8. 5-Propionamido-4-carbamoyl-2- (m-methylphenyl) imidazole. 1
9. 5-Acetamido-4-methoxycarboriyl~2- (p-fluorophenyl) -imidazole. 20. 5-Acetamido-4-ethoxycarbonyl-2-phenyl imidazole. 21. 5-Acetamido-4-ethoxycarbonyl-2- (p-fluorophenyl) -imidazole. 22. 5-Acetamido-4-ethoxycarbonyl-2- {3 ,4-dimethoxyphenyl) -imidazole. 38357/3 23. 5-Acetamido-4-ethoxycarbonyl-2- (p-trifluoromethyl-phenyl) imidazole. 24. 5-Acetamido-4-ethoxycarbonyl-2- (p-nicrophenyD-imidazole. 25. A process for the preparation of a compound as claimed in Claim 1 which comprises the reaction of a compound of the formula (VI) : with an acylating derivative of an acid of general formula EO.CO.E3. 25. A process for the preparation of a compound as claimed in any of Claims 11-14 which comprises the acetylation of a compound of the formula: 27. A process as in Claim 26 wherein the acetylatfrig agent is the acid chloride/ the acid bromide or the acid anhydride. 28. A pharmaceutical composition which comprises a compound as claimed in Claim 1 together with one or more pharmaceutically acceptabl 29. A pharmaceutical administrable unit dosage form which contains from 5 to 500 mgs. of a compound as claimed in Claim 11. 38357/3 30. A composition as in Claim 29 which contains 5-acetamido-4-carbamoyl-2-phenylimidazole. 31. A compound as in any of Claims 1-24 when prepared by a process as in Claim 2:5. 32- A compound as in any of Claims 11-15 when prepared by a process as in Claim 26. 33. A process for the preparation of a compound as claimed in any of Claims 1-24 substantially as described in any of Examples 1-24 herein. EE:mr
IL38357A 1971-08-18 1971-12-14 2-phenyl-4-acylamido-imidazole derivatives,their preparation and pharmaceutical compositions containing them IL38357A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3871671A GB1378381A (en) 1971-08-18 1971-08-18 Imidazoles

Publications (2)

Publication Number Publication Date
IL38357A0 IL38357A0 (en) 1972-02-29
IL38357A true IL38357A (en) 1976-08-31

Family

ID=10405251

Family Applications (1)

Application Number Title Priority Date Filing Date
IL38357A IL38357A (en) 1971-08-18 1971-12-14 2-phenyl-4-acylamido-imidazole derivatives,their preparation and pharmaceutical compositions containing them

Country Status (11)

Country Link
JP (1) JPS4829771A (en)
BE (1) BE777738A (en)
CH (1) CH584203A5 (en)
DE (1) DE2200499A1 (en)
ES (1) ES398587A1 (en)
FR (1) FR2149329B1 (en)
GB (1) GB1378381A (en)
IL (1) IL38357A (en)
NL (1) NL7200080A (en)
SE (1) SE376418B (en)
ZA (1) ZA7238B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4197596A1 (en) * 2021-12-15 2023-06-21 Eberhard Karls Universität Tübingen Medizinische Fakultät Imidazole derivatives for the treatment and prophylaxis of infectious diseases

Also Published As

Publication number Publication date
ES398587A1 (en) 1974-09-16
SE376418B (en) 1975-05-26
CH584203A5 (en) 1977-01-31
FR2149329A1 (en) 1973-03-30
GB1378381A (en) 1974-12-27
FR2149329B1 (en) 1975-12-26
JPS4829771A (en) 1973-04-19
BE777738A (en) 1972-07-05
IL38357A0 (en) 1972-02-29
ZA7238B (en) 1972-09-27
NL7200080A (en) 1973-02-20
DE2200499A1 (en) 1973-03-08

Similar Documents

Publication Publication Date Title
US4260769A (en) 5,5-Diphenylhydantoins
IE38886L (en) Quinoline-3-carboxamidotetrazole derivatives
GB1337280A (en) 5-phenyl-isoxazole-3-carboxylic acids and their derivatives
US4455305A (en) Composition for the treatment of colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronic nonspecific colitis and diverticulitis and the use of salicylazobenzoic acid for the preparation of such compositions
NO20044810L (en) Instant release pharmaceutical formulation
JPH07505380A (en) Melamine derivatives for use in cancer treatment
IL27058A (en) Novel salts of 5-(p-(2-pyridylsulphamyl)-phenylazo)-salicylic acid and method of producing same
US4163058A (en) Derivatives of 5,5-diphenylhydantoin exhibiting enhanced solubility and the therapeutic use thereof
IE37795L (en) Quinaldamide derivatives
GB1411583A (en) Aminophenyl-substituted alkyl-heterocyclic derivatives and processes for producing them
IL38357A (en) 2-phenyl-4-acylamido-imidazole derivatives,their preparation and pharmaceutical compositions containing them
GB1303171A (en)
FI73970C (en) FOERFARANDE FOER FRAMSTAELLNING AV PHARMACEUTISKT AKTIVA 2-AMINO-3- (HALOBENSOYL) -METHYL-PHENYL ETHYL OCH ESTRAR OCH SALTER DAERAV.
GB1252847A (en)
US3718655A (en) Certain diisoniazid methane sulfonate complexes
GB1174349A (en) Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof
US3019226A (en) Piperazine salt of phytic acid
US4335119A (en) Quick-acting diuretic compositions
US3840539A (en) Phthalazine derivatives
US4377583A (en) N-Methyl-D-glucamine salt of with 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-carboxylic acid
HUP0202438A2 (en) Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation
CN1167765A (en) Process for isolating or purifying cefonicid and process for preparing salts thereof
US3959305A (en) Acylamino imidazoles
TWI429439B (en) And a therapeutic agent for inflammatory bowel disease using a uracil derivative as an active ingredient
US3968145A (en) Methyl 2(1 chloronaphth-2-yloxy)propionate